Tag Archives: CLS Bank

Oral Arguments – Can Alice Get Out Of “Wonderland”?

And by “Wonderland” I am referring to the maze of hypotheticals and questions that were thrown at Carter G. Phillips by the Justices during his opening argument for Alice Corp. (A copy of the transcript can be found at the … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | 1 Comment

Top Ten IP Stories from 2013

I admit it, I like lists, even completely subjective ones like this one, that is tilted toward patent law and prep/pros. So in no particular order, except for number one, here we go:   Myriad [Add your pun title here!]. … Continue reading

Posted in Patent Eligible Subject Matter, Stem Cells/Cloning, USPTO Practice and Policy | Tagged , , , , , , , , | Leave a comment

Bosch, Ultramercial, Commil, Fresenius: All-Star Break

A guest post from Ron Schutz of Robins, Kaplan, Miller & Ciresi The Federal Circuit goes into the symbolic half-way point of summer leading the league with a series of homerun opinions. To keep the games back gap on updates … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , | Leave a comment

CLS Bank International v. Alice Corporation: Poison Apple

This is a guest post from Ron Schutz of Robins, Kaplan, Miller & Ciresi. Move over Snow White.  A deeply-divided Federal Circuit in CLS Bank Int’l.  v. Alice Corp. Pty. Ltd., issued a per curiam opinion that dwarfs the scope … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , | Leave a comment